VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 96 filers reported holding VBI VACCINES INC in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $62,054 | -22.5% | 204,800 | 0.0% | 0.00% | – |
Q4 2022 | $80,097 | -39.8% | 204,800 | +8.4% | 0.00% | – |
Q3 2022 | $133,000 | -4.3% | 188,900 | +9.9% | 0.00% | – |
Q2 2022 | $139,000 | -37.7% | 171,900 | +28.2% | 0.00% | – |
Q1 2022 | $223,000 | -28.5% | 134,100 | +0.4% | 0.00% | – |
Q4 2021 | $312,000 | -24.8% | 133,500 | 0.0% | 0.00% | – |
Q3 2021 | $415,000 | -29.1% | 133,500 | -23.5% | 0.00% | – |
Q2 2021 | $585,000 | +73.6% | 174,600 | +61.2% | 0.00% | – |
Q1 2021 | $337,000 | -16.8% | 108,300 | -26.5% | 0.00% | – |
Q4 2020 | $405,000 | -48.9% | 147,300 | -46.8% | 0.00% | – |
Q3 2020 | $792,000 | -30.0% | 276,800 | -24.1% | 0.00% | -100.0% |
Q2 2020 | $1,131,000 | +674.7% | 364,800 | +137.2% | 0.00% | – |
Q1 2020 | $146,000 | +17.7% | 153,800 | +70.7% | 0.00% | – |
Q4 2019 | $124,000 | +195.2% | 90,100 | 0.0% | 0.00% | – |
Q3 2019 | $42,000 | -62.2% | 90,100 | -5.0% | 0.00% | – |
Q2 2019 | $111,000 | – | 94,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 52,335,002 | $86,876,000 | 1.74% |
GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $3,117,000 | 0.25% |
Newbridge Financial Services Group, Inc. | 172,969 | $287,000 | 0.14% |
Virtus ETF Advisers LLC | 69,220 | $115,000 | 0.05% |
ArchPoint Investors | 65,000 | $108,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 115,365 | $192,000 | 0.03% |
GRIMES & COMPANY, INC. | 281,077 | $467,000 | 0.02% |
Cambridge Investment Research Advisors, Inc. | 2,189,700 | $3,635,000 | 0.02% |
WEALTHSOURCE PARTNERS, LLC | 143,500 | $238,000 | 0.02% |
CARDIFF PARK ADVISORS, LLC | 64,100 | $106,000 | 0.02% |